Valeur202020212022202320242025TTMFlux de trésorerie liés aux activités d'investissement17.28 M16.61 M1.42 M-4.34 M7.34 M750 K250 KFlux de trésorerie liés aux activités de financement20.56 M21.9 M4.52 M5.51 M9 0006 0001.79 MFlux de trésorerie disponible-30.22 M-25.87 M-13.98 M-15.29 M-9.63 M-4.74 M-4.25 M
Arcadia Biosciences, Inc. - Common Stock
Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.